ReachRxResearch
Home
Research
Sign Up
Digital Defocus Vision Training Using Virtual Reality for Myopia Control
Back to Research Hub
  1. Home
  2. Research Hub
  3. Digital Defocus Vision Training Using Vi…

Digital Defocus Vision Training Using Virtual Reality for Myopia Control

JAMA Ophthalmology·August 27Open Access
OphthalmologyLimited evidenceMyopiaRandomized Controlled TrialVirtual Reality Vision TrainingChild

Summary

View source

What was studied

This single-center RCT in Guangzhou, China evaluated whether a home-based, head-mounted VR digital defocus vision training (DDVT) system (15 min/day) plus single-vision spectacles (SVS) could slow myopia progression versus SVS alone in 120 children aged 6–12 years over 6 months (July 2024–September 2025).

Key findings

Over 6 months, axial length (AL) grew 0.15 mm (DDVT+SVS) vs. 0.25 mm (SVS alone) — a difference of 0.11 mm (95% CI, 0.07–0.15 mm; P < .001). Spherical equivalent refraction (SER) changed by −0.23 D vs. −0.46 D (difference = −0.23 D; 95% CI, −0.35 to −0.11 D; P = .003). No training-related adverse events occurred, but a small statistically significant VA difference (0.03 logMAR) favored the SVS-alone group.

Study limitations

- Single-center trial with only a 6-month follow-up limits conclusions about long-term clinical relevance or durability of the effect. - The absolute differences in AL (0.11 mm) and SER (0.23 D) are small; whether they translate to meaningful reduction in myopia-related morbidity is unknown. - No masking was possible given the nature of the intervention, introducing potential performance bias.

Clinical implications

VR-based DDVT shows a statistically significant but small reduction in axial elongation and myopic shift over 6 months in children 6–12 years old. Clinicians may consider it as an adjunct to standard correction, but should counsel families that long-term benefit is unproven and further study is needed.

Caveats

  • A statistically significant VA difference (0.03 logMAR worse in the DDVT group) was noted but its clinical significance is unclear — the authors do not appear to flag it as an adverse event.
  • The full text is under embargo until August 27, 2027; this summary is based solely on the published abstract and results excerpt.
  • Trial was conducted at a single center in China; generalizability to other populations and healthcare settings is uncertain.

Related Questions

Explore related topics

What myopia control interventions most effectively slow axial elongation in school-age children?How does VR-based vision training compare to orthokeratology or atropine for pediatric myopia control?What are the safety considerations of daily head-mounted VR use in children aged 6 to 12 years?

Publication Details

Year
2026
Journal
JAMA Ophthalmology
Sample Size
n=120
Source
View article
Keep scrolling
More content below.
Up Next